Schedule 13G ownership disclosure
BRAINSTORM CELL THERAPEUTICS
Security class unavailable · CUSIP: 10501E201
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,060,000
- Percent of class
- 6.2500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-013878
- Form type
- SC 13G
- Filer
- BRAINSTORM CELL THERAPEUTICS INC.
- CIK
- CIK 1137883
- Filed
- Feb 12, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership